These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy. Adkins JC; Noble S Drugs; 1998 Mar; 55(3):437-60. PubMed ID: 9530548 [TBL] [Abstract][Full Text] [Related]
11. Role of new and established antiepileptic drugs. Leppik IE Epilepsia; 1998; 39 Suppl 5():2-6. PubMed ID: 9737436 [No Abstract] [Full Text] [Related]
14. Tiagabine in the treatment of epilepsy--a clinical review with a guide for the prescribing physician. Schmidt D; Gram L; Brodie M; Krämer G; Perucca E; Kälviäinen R; Elger CE Epilepsy Res; 2000 Oct; 41(3):245-51. PubMed ID: 10962215 [TBL] [Abstract][Full Text] [Related]
15. [Tiagabine--own experience in the refractory epilepsy treatment]. Błaszczyk B Wiad Lek; 2013; 66(2 Pt 2):175-9. PubMed ID: 25775813 [TBL] [Abstract][Full Text] [Related]
16. [Clinical implications of pharmacology and pharmacokinetics of tiagabine]. Pita-Calandre E Rev Neurol; 1999 Feb 1-15; 28(3):337-9. PubMed ID: 10714305 [TBL] [Abstract][Full Text] [Related]